Moreover, the level of CD3+ and CD8+ T lymphocytes in a tumor invasive margin in colorectal carcinoma was recently introduced as an immunoscore, which serves as a prognostic factor for colorectal carcinoma patients and is now approved as an addition to the conventional tumor-node-metastasis (TNM) staging [6]. This evidence concerns the gene CD8A and colorectal carcinoma.